Besides, HR for NQO1 was significantly increased for the PFI of rectum adenocarcinoma and bladder urothelial carcinoma (Supplementary Figure S5B) and DSS of kidney renal clear cell carcinoma (Supplementary Figure S5C). This evidence concerns the gene NQO1 and bladder transitional cell carcinoma.